Aarey Drugs & Pharmaceuticals Ltd.
BSE: 524412 | Sector: Health care |
NSE: AAREYDRUGS | ISIN Code: INE198H01019 |
BSE 00:00 | 20 May | 40.00 |
0.30 (0.76%) |
OPEN
41.95 |
HIGH
41.95 |
LOW
39.70 |
NSE 00:00 | 20 May | 40.00 |
0.35 (0.88%) |
OPEN
40.15 |
HIGH
42.30 |
LOW
39.60 |
OPEN | 41.95 |
PREVIOUS CLOSE | 39.70 |
VOLUME | 9787 |
52-Week high | 64.40 |
52-Week low | 30.20 |
P/E | 11.66 |
Mkt Cap.(Rs cr) | 102 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 915.50 | 3.52 | 966.90 | 652.75 | 219655.91 |
Divi's Lab. | 4306.60 | 2.53 | 5425.00 | 3790.00 | 114318.70 |
Cipla | 978.60 | 4.32 | 1083.15 | 850.00 | 78953.45 |
Dr Reddy's Labs | 4246.30 | 8.10 | 5613.65 | 3655.00 | 70666.92 |
Apollo Hospitals | 3667.65 | 0.94 | 5930.70 | 3122.90 | 52733.47 |
Gland Pharma | 3070.20 | -0.83 | 4350.00 | 2801.00 | 50535.49 |
Piramal Enterp. | 1917.10 | 1.19 | 3013.00 | 1671.35 | 45751.59 |
Torrent Pharma. | 2664.45 | 2.82 | 3304.45 | 2485.00 | 45087.82 |
Biocon | 339.65 | 5.17 | 420.25 | 314.90 | 40778.38 |
Abbott India | 17972.40 | -0.90 | 23902.30 | 15525.00 | 38191.35 |
Zydus Lifesci. | 357.15 | 5.48 | 668.85 | 319.40 | 36561.45 |
Max Healthcare | 374.60 | 1.81 | 472.60 | 205.00 | 36322.34 |
Alkem Lab | 3001.30 | 2.87 | 4067.70 | 2835.00 | 35880.54 |
Aurobindo Pharma | 557.85 | 6.68 | 1043.00 | 521.00 | 32684.43 |
Laurus Labs | 574.45 | 2.53 | 723.55 | 433.20 | 30868.07 |
Lupin | 638.40 | 0.58 | 1267.50 | 620.35 | 29015.28 |
Glaxosmi. Pharma | 1543.60 | 1.30 | 1917.00 | 1433.05 | 26150.13 |
Ipca Labs. | 989.00 | 2.53 | 1383.55 | 917.00 | 25090.93 |
Syngene Intl. | 559.15 | 3.02 | 699.95 | 508.10 | 22445.96 |
Pfizer | 4352.00 | 2.06 | 6164.80 | 4077.80 | 19910.40 |
Quick Links for Aarey Drugs & Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices